Content overview: “Japan approves world’s first regenerative medicines using iPS cells | Nova Global News”. Japan’s health ministry panel on Thursday approved the commercialisation of two regenerative medicine products prepared from iPS cells, the first of their... Japan’s health ministry panel on Thursday approved the commercialisation of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. The two drugs, ReHeart developed by Cuorips, a start-up originating from the University of Osaka, and Amchepry by Sumitomo Pha Nova Global News curates publicly available headlines and summaries with source attribution.
Third-party article rights, trademarks, images, and publisher names belong to their respective owners; read the original article at the source for full context. Part of the Nova Ecosystem — the platform where AI apps, news, and tools are built and deployed. [ LIVE 🧠 Nova Ecosystem PLATFORM Our Platform Nova AI MetaBrain 84 AI Assistants — Videos, images, code & more. The full version stays on the original page, which this listing opens directly.